2001
DOI: 10.4049/jimmunol.167.12.7060
|View full text |Cite
|
Sign up to set email alerts
|

Role of IL-18 in Acute Lung Inflammation

Abstract: We have examined the role of IL-18 after acute lung inflammation in rats caused by intrapulmonary deposition of IgG immune complexes. Constitutive IL-18 mRNA and protein expression (precursor form, 26 kDa) were found in normal rat lung, whereas in inflamed lungs, IL-18 mRNA was up-regulated; in bronchoalveolar (BAL) fluids, the 26-kDa protein form of IL-18 was increased at 2–4 h in inflamed lungs and remained elevated at 24 h, and the “mature” protein form of IL-18 (18 kDa) appeared in BAL fluids 1–8 h after o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
74
0

Year Published

2003
2003
2018
2018

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 95 publications
(78 citation statements)
references
References 50 publications
4
74
0
Order By: Relevance
“…Human IL-18BP also decreased IFN-␥ production and hepatic damage in mice after injection of Con A (20). The in vivo production of TNF-␣ and IL-1␤ by bronchoalveolar cells in immune complex-induced lung inflammation in rats also was decreased by intratracheal administration of IL-18BP (21). Thus, the exogenous administration of IL-18BP reduces the level of proinflammatory cytokines in different animal models of disease.…”
Section: Discussionmentioning
confidence: 76%
“…Human IL-18BP also decreased IFN-␥ production and hepatic damage in mice after injection of Con A (20). The in vivo production of TNF-␣ and IL-1␤ by bronchoalveolar cells in immune complex-induced lung inflammation in rats also was decreased by intratracheal administration of IL-18BP (21). Thus, the exogenous administration of IL-18BP reduces the level of proinflammatory cytokines in different animal models of disease.…”
Section: Discussionmentioning
confidence: 76%
“…Moreover, we show that generation of such moieties may be subject to novel caspaseindependent processing pathways. IL-18 is a known enhancer of neutrophil effector function [20] that, when introduced into murine models, promotes neutrophilpredominated local inflammation [38,39]. In contrast, systemic inflammation following LPS injection is suppressed by anti-IL-18 antibodies, with concordant reduction in tissue neutrophil invasion to liver or lung [40].…”
Section: Discussionmentioning
confidence: 99%
“…26 IL-18 is a known mediator of inflammation, with studies showing its role in many tissues including lung, heart, bowel, and cartilage. [27][28][29][30] IL-18 is activated by cleavage by caspase-1, and mice deficient in the enzyme are protected from AKI induced by IL-18 injection. 31 Further study showed the neutrophil-independent role that IL-18 has in ischemic AKI.…”
Section: Discussionmentioning
confidence: 99%